I’m n 2/28/2024, Sarepta Therapeutics (SRPT) reported earnings of $0.51 per share on revenue of $396.78 million for the fourth quarter ended December 2023. The consensus earnings estimate was $0.01 per share on revenue of $384.54 million.
SRPT bullish movement in a simple resistance and support testing strategy
Entry @ 125
Stop loss @ 114
TP 1 @ 134
TP 2 @ 141
TP 3@ 150-156 range
Keep it simple
If you haven`t bought SRPT here:
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than $10Mil that SRPT Sarepta Therapeutics will trade above $135 by November 17.
Some...
SRPT is at a very strong support at the moment and entries can be made now if fundamentals of the company are strong
Entry @ CMP or 107 to 100
SL @ 97
TP 1 @ 120
TP 2 @ 132
This is when we are expecting that it will bounce back up from the strong support of 105
104-106 range (Strong Support)
Its trading in a range and entries is good for people who...
Looking at the SRPT Sarepta Therapeutics options chain, i would buy the $125 calls with
2023-2-17 expiration date for about
$7.10 premium.
Looking forward to read your opinion about it.
Prediction: SRPT (Sarepta) is Bull to at least 72.81
Reasons:
A good/decent Bull Pattern has emerged (Before closing) that is pointing upwards, and the Trends momentum is strong enough to push through the current resistance and reach the next resistance point of 72.81. And also, the main index for small biotech XBI is also showing bull signs.
As you can see on...
SRPT looks like she will pop soon. The bollinger bands are contracted and are squeezing the keltner channel for a classic bollinger band squeeze.
It is not a given which way this will pop, could go up or down..but a move is coming.
There are pocket pivots under price
Short is a bit over 9%. Negative volume is high on SRPT.
Keltner Channels are...
Some of the biotech industry seems to be recovering after most suffering a long hard fall.
SRPT gapped down, way down, did the dead cat bounce dance and regained a bit only to form a symmetrical triangle that broke to the downside. Then a descending triangle and has fallen down from each triangle the designated amount but could fall further. The low during these...
Breakaway Gap
Hook Reversal
Price Crossed SMA13
RSI divergence
Williams %R Crossed -80
Entry 74
Stop 67
Target 100
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
This is a stock ive lost on before - so be warned
However, it seems so oversold and if price pushes lower I will likely re-enter, the stock has a strong pipeline of goods and has had some good news recently (Amondys 45 FDA approval) which hasnt really been reflected in the stock price.
RSI is touching oversold
Average Analyst price target is still $130
Price...
